ArticleRadiology case reports2026
Patient with two rare diseases-Renal coloboma syndrome and craniopharyngioma.
Article in Radiology case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Renal coloboma syndrome (RCS), also known as papillorenal syndrome, is a rare inherited condition caused by PAX2 mutations and typically affects both the eyes and kidneys, while craniopharyngioma is a rare brain tumor of childhood that often grows slowly but can cause significant local compression. We report the case of a 13-year-old Latvian girl who was diagnosed with both conditions, representing an uncommon overlap of a congenital genetic syndrome and an acquired intracranial tumor. She initially presented with long-standing visual impairment related to congenital optic nerve abnormalities and was later found to have a calcified sellar-suprasellar mass consistent with craniopharyngioma, which contributed to progressive optic pathway compression and neurological symptoms. Genetic testing confirmed a pathogenic PAX2 mutation (c.76dup, p.(Val26Glyfs*28)). This case illustrates how pre-existing congenital eye disease can obscure the recognition of a developing brain tumor and highlights the importance of correlating imaging findings with the broader clinical and genetic context. It also underlines the need for coordinated, multidisciplinary care and careful long-term follow-up in patients with rare overlapping conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.